Cure Hepatitis C Act of 2026 aims to eliminate hepatitis C in the U.S. by enhancing screening, treatment access, and public awareness.
The Cure Hepatitis C Act of 2026 mandates the Department of Health and Human Services to establish a subscription program for hepatitis C treatments, ensuring access for high-risk populations. It coordinates with state Medicaid and CHIP programs to verify enrollment before treatment. The Act also eliminates cost-sharing for hepatitis C treatments in Medicare Part D for plan years 2028 through 2032. Additionally, it creates a Hepatitis C Elimination Program, funds public awareness campaigns, and supports diagnostic test development.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.